Profile of Obesity and Comorbidities in Elderly Patients with Heart Failure
Received 3 February 2020
Accepted for publication 5 April 2020
Published 21 April 2020 Volume 2020:15 Pages 547—556
Checked for plagiarism Yes
Review by Single-blind
Peer reviewer comments 2
Editor who approved publication: Dr Richard Walker
Alexandra Dădârlat-Pop,1 Adela Sitar-Tăut,2 Dumitru Zdrenghea,3 Bogdan Caloian,3 Raluca Tomoaia,1 Dana Pop,3 Anca Buzoianu4
1Cardiology Department, "Iuliu Haţieganu" University of Medicine and Pharmacy, Cluj-Napoca, Romania; 2Internal Medicine Department, 2nd Department, Medical Clinic IV, Cluj-Napoca, Romania; 3Internal Medicine Department, Cardiology - Rehabilitation Department, Clinical Rehabilitation Hospital, Cluj-Napoca, Romania; 4Department of Pharmacology, Toxicology and Clinical Pharmacology, "Iuliu Haţieganu" University of Medicine and Pharmacy, Cluj-Napoca, Romania
Correspondence: Dana Pop Email email@example.com
Background and Purpose: In Romania, robust data about the prevalence of obesity and heart failure are lacking, especially in the elderly; therefore, this study aims to analyze the profile of overweight and obese patients aged > 65 years admitted to a Romanian hospital for worsening heart failure, and also their risk in the presence of comorbidities.
Patients and Methods: This cross-sectional study was conducted in 126 consecutive elderly patients with overweight and obesity admitted to a Romanian hospital for worsening heart failure. They were divided into three groups: with reduced (< 40%) – HFrEF, mid-range (40– 49%) – HFmrEF and preserved (≥ 50%) ejection fraction – HFpEF. Obesity was defined according to the body mass index (BMI) status: obesity, ≥ 30 kg/m2; overweight, 25– 29.9 kg/m2. The Charlson Comorbidity Index (CCI) was calculated to evaluate the severity of comorbidity, with a score ranging from 2 (only heart failure present and age > 65 years) to 30 (extensive comorbidity).
Results: NT-proBNP values are negatively correlated with BMI only in patients with HFpEF. Creatinine clearance (p=0.0166), the presence of atrial fibrillation (p=0.0095) and NYHA functional class were independent predictors of increased NT-proBNP values. CCI score is negatively correlated with NT-proBNP values in patients with HFmrEF (r= − 0.448, p=0.009) and HFpEF (r= − 0.273, p=0.043). The CCI risk was not significantly different between the three groups.
Conclusion: Elderly heart failure patients with overweight or obesity have particular characteristics in terms of NT-proBNP values and presence of comorbidities. In the studied population, NT-proBNP levels were strongly influenced by renal function, NYHA functional class, the presence of atrial fibrillation and left ventricular ejection fraction.
Keywords: obesity, heart failure, comorbidity, elderly patients
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF] View Full Text [HTML][Machine readable]